Shares of Catalyst Pharmaceuticals rose 5.59% to $3.78 at 11:48 EST on Wednesday, following last session’s upward trend. NASDAQ Composite is jumping 1.68% to $13,418.58, following last session’s upward trend, This seems, up until now, an all-around positive trend exchanging session today.

Catalyst Pharmaceuticals’s last close was $3.58, 39.68% under its 52-week high of $5.28.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 0.8% for the ongoing quarter and 5.5% for the next. The company’s growth estimates for the present quarter is 12.5% and a drop 20% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.

Volatility

Catalyst Pharmaceuticals’s last day, last week, and last month’s average volatility was a positive 2.58%, a positive 0.75%, and a negative 0.27%, respectively.

Catalyst Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 4.35%, 4.01%, and 4.35%, respectively.

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $3.78 at 11:48 EST, way below its 52-week high of $5.28 and way higher than its 52-week low of $2.55.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s worth is above its 50-day moving average of $3.54 and higher than its 200-day moving average of $3.61.

LEAVE A REPLY

Please enter your comment!
Please enter your name here